Scientists identified CD62L as a marker to reveal the heterogeneity within progenitors. They confirmed that CD62L-negative common myeloid progenitors (CMPs) represent “bona fide” CMPs, and CD62L-high CMPs are mostly restricted to granulocyte-monocyte progenitors potentials in mice and humans.
[Stem Cell Reports]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
169257
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
